Profile
Ottavio V.
Vitolo worked as a Senior Medical Director at Pfizer Inc. from 2013 to 2017, an Associate Medical Director at Shire Human Genetic Therapies, Inc. from 2012 to 2013, Vice President of Clinical Development at Homology Medicines, Inc. from 2017 to 2018, and Chief Medical Officer & Senior Vice President at Relmada Therapeutics, Inc. from 2018 to 2020.
Vitolo holds a doctorate from Sapienza University of Rome and a graduate degree from Harvard Medical School.
Former positions of Ottavio V. Vitolo
| Companies | Position | End |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/03/2020 |
| Q32 BIO INC. | Corporate Officer/Principal | 28/02/2018 |
| PFIZER, INC. | Corporate Officer/Principal | 31/12/2016 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 31/03/2013 |
Training of Ottavio V. Vitolo
| Harvard Medical School | Graduate Degree |
| Sapienza University of Rome | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Ottavio V. Vitolo